Trial passed on one line: can the product be approved plant-wide?
Summary
Only if the other lines match the trial line in material, equipment and operating conditions; otherwise approval covers only what the trial tested. Even a matching line gets a short confirmation check, and a different upstream process, water source or per-line customer rule also limits the approval. Automotive and drug rules agree: approval rests on the process actually run.
Ford requires "additional PV testing" on each additional production stream a supplier adds to meet capacity (Ford PPAP customer-specific requirements, 2026).
FDA SUPAC-IR treats a move to equipment of a different design and operating principle as a higher change level than equipment of the same design, even at a different capacity (FDA SUPAC-IR, 1995).
FDA SUPAC-IR places changes in mixing times and operating speeds outside validation ranges one level above the same changes within them (FDA SUPAC-IR, 1995).
In its FAQ on layout inspection (clause 8.6.2), the IATF states that product requalification "would normally imply full validation to all product approval requirements (e.g. PPAP or PPA)" (IATF 16949 FAQs, 2026).
When can a one-line trial support a plant-wide approval, and when not?
A one-line trial supports a plant-wide approval only for lines where every condition that can change the product's performance is the same as on the trial line. The trial tested one combination of material, equipment, operating window and upstream process, and the approval can reach only as far as that combination repeats. To use the table, take the trial record and the other line's equipment list, materials and operating log side by side. Read each row against the other line, and stop at the first row that says not covered: that line needs its own evidence. A line that clears every row still gets a confirmation check, because two lines that look alike on paper can differ in water, wear or upstream steps.
The table below decides which lines the passed trial covers.
Condition on the other line | Verdict | Why |
|---|---|---|
Same material and grade, equipment type, operating window, upstream process and water | Covered, after a short confirmation check | The tested combination repeats |
Different material, alloy, grade or product being made | Not covered | The product meets a material the trial never tested |
Equipment of a different design or operating principle | Not covered | A higher change level than same-design equipment (FDA SUPAC-IR, 1995) |
Same equipment design, different capacity | Covered only with a confirmation run | Same design at another capacity is the lowest equipment change level (FDA SUPAC-IR, 1995) |
Temperature, speed or concentration outside the trial range | Not covered | Untested range; SUPAC-IR puts mixing times and operating speeds outside validated ranges a level higher (FDA SUPAC-IR, 1995) |
Different upstream process or water source | Not covered | The inputs the product sees have changed |
Customer or regulator requires approval per line or stream | Not covered by an internal decision | Additional streams need their own validation testing (Ford, 2026) |
The decisive row is equipment design: a line built on another operating principle is a new trial, however similar its output looks.
What did a one-line trial actually prove?
A one-line trial proved that the product met the trial's criteria under the conditions logged on that line, during that period, with that material and upstream process. It did not prove how the product behaves anywhere those conditions differ. The automotive approval system is built on this point. AIAG describes the Production Part Approval Process (PPAP) as confirming consistent quality "during an actual production run at production rates" (AIAG, 2026), and General Motors requires suppliers to meet IATF 16949 clause 8.3.4.4, the product approval process, by complying with the AIAG PPAP manual (GM, 2025).
Ford applies the logic to lines directly. Its PPAP requirements state that "additional PV testing needs to be performed on those additional production streams" when a supplier needs more than one stream for capacity (Ford, 2026), and its initial process study must include "all tools, all cavities, all streams, all shifts" (Ford, 2026). A chemical trial is not a part approval, but the reasoning carries over: a result covers the stream that produced it. Before extending an approval, write down what the trial tested, item by item, from the run log.
How do you extend approval from one line to other lines?
You extend approval from one line to another by comparing the two lines condition by condition against the trial record, then running a short confirmation check where they match and a new trial where they do not. Start with the list of what the trial tested: material and grade, equipment type and design, operating window, upstream process, water and the measured criteria.
For each other line, mark each condition as same, different within the trial range, or outside it. Lines that match on every condition get a confirmation check: the same measurements over a shorter period, judged against the original criteria. Lines with a different equipment design, material or upstream process get their own trial plan. FDA SUPAC-IR shows the graded approach: equipment "of the same design and operating principles of the same or of a different capacity" sits at the lowest level, while "a different design and different operating principles" sits higher (FDA, 1995).
Treat the extension as a controlled change. ISO 9001:2026, the edition published on 16 September 2026, keeps a clause on control of changes (ISO 9001:2026, clause 8.5.6), so a quality system expects the extension to be reviewed and recorded, not assumed.
How should an approval document state the lines it covers?
An approval document should name the exact lines, equipment, materials, operating ranges and period that the trial covered, and state that any other line needs a confirmation check or its own trial. A sentence such as "approved for plant use" invites misreading; "approved for line 2, alloy 6061, bath 50 to 55 °C, upstream degreaser unchanged" (illustrative) does not.
Write four parts. First, the scope: lines and equipment by identifier, materials and grades, operating window and the trial dates. Second, the evidence: the trial plan, the logged conditions and the results against the fixed criteria. Third, the exclusions: lines, materials or ranges not tested. Fourth, the conditions for extension: which check each excluded line needs and who signs it off.
Then compare the approved scope with the original recommendation. If the recommendation promised use on lines the trial never touched, the gap must appear in the document. Lubinpla, an applied AI company for specialty chemical technical reasoning, works such a case from your own documents and site history, stating the scope a passed result actually covers and checking it against the original recommendation, in one cited document for your review.
Frequently asked questions
Which differences between lines void a plant-wide approval?
Differences in the material or grade processed, the equipment design or operating principle, the operating window beyond the trial range, the upstream process or water source, and customer rules that require approval per stream all void a plant-wide approval for the line concerned. Ford, for example, requires additional validation testing on each additional production stream (Ford, 2026).
Is a short confirmation run enough for an identical line?
Usually, if the line matches the trial line on every condition in the trial record and the confirmation run uses the same criteria and measurements. Same-design equipment at a different capacity is the lowest equipment change level in FDA SUPAC-IR, yet the guidance still asks for stability data on one batch (FDA, 1995).
Does a plant-wide approval need the customer's sign-off?
It does where the customer's quality system requires it. In the automotive supply chain, product approval follows customer-defined processes: General Motors requires suppliers to comply with the AIAG PPAP manual (GM, 2025), and Ford requires additional validation testing on each production stream a supplier adds for capacity (Ford, 2026). Check the customer's specific requirements before extending an approval.